Paclitaxel numuti ukomeye wa anticancer wabaye igice cyingenzi mubuvuzi bwa kanseri yubuvuzi bitewe nuburyo bwihariye hamwe nibyiza byo kuvura.Uyu muti wabanje gutandukanywa n’igiti cyitwa yew cya Pasifika (Taxus brevifolia) mu 1971, kandi nyuma y’imyaka myinshi y’ubushakashatsi n’iterambere, cyakoreshejwe cyane mu bice byinshi bya kanseri.Uru rupapuro ruzamenyekanisha ibice byingenzi byo gusaba byapaclitaxel APIn'uruhare rwarwo muri utwo turere.
1. Kuvura kanseri yintanga:
Yamazakiikoreshwa kenshi mu kuvura kanseri yintanga.Irashobora gukoreshwa nkumurongo wambere cyangwa, hamwe nindi miti, nkumuti wongeyeho kanseri yintanga yateye imbere.Paclitaxel ibuza neza gukura no gukwirakwira kwingirangingo za kanseri ibangamira mitito ya selile.
2. Kuvura Kanseri y'ibere:
Ku barwayi ba kanseri y'ibere, paclitaxel ikoreshwa kenshi hamwe n'indi miti irwanya kanseri, cyane cyane kuri kanseri y'ibere yateye imbere cyangwa igaruka kenshi.Ifasha kugabanya ubunini bwikibyimba no kunoza uburyo bwo kuvura.
3. Kuvura Kanseri y'ibihaha:
Kanseri y'ibihaha itari ntoya (NSCLC) ni ubwoko bwa kanseri y'ibihaha, kandi paclitaxel ikoreshwa cyane nk'umurongo wa mbere cyangwa ubuvuzi bwa NSCLC.Ifasha kugabanya umuvuduko wikura ryibibyimba no kuzamura imibereho.
4. Kuvura kanseri y'inkondo y'umura:
Paclitaxel ikoreshwa ifatanije na Cisplatin mu kuvura kanseri y'inkondo y'umura, akenshi mu rwego rwo kuvura imishwarara.Ubu buryo bwo kuvura bwazamuye ubuzima bw'abarwayi ba kanseri y'inkondo y'umura.
5. Kuvura kanseri yo mu gifu:
Paclitaxel rimwe na rimwe ikoreshwa mu kuvura kanseri yo mu gifu cyangwa Esophageal, akenshi ifatanije n’indi miti irwanya kanseri kugira ngo igabanye imikurire ikwirakwira.
6. Kuvura Kanseri ya Prostate:
Paclitaxel ifite kandi ubushobozi bwo kuvura kanseri ya prostate, cyane cyane iyo kanseri imaze gukwirakwira mu zindi ngingo.Irashobora kugenzura imikurire yibibyimba no kugabanya ibimenyetso.
7. Kuvura kanseri yandura:
Paclitaxel ikoreshwa kenshi ifatanije nindi miti ifasha abarwayi kurokoka kanseri yandura.
8. Kuvura lymphoma itari hodgkin:
Yamazakiikoreshwa kandi mukuvura lymphoma itari Hodgkin, akenshi ifatanije nindi miti ya chimiotherapie kugirango igabanye lymphoma.
9. Kuvura ibibyimba byubwonko bwibanze cyangwa metastatike:
Paclitaxel rimwe na rimwe ikoreshwa mu kuvura ibibyimba by'ubwonko bw'ibanze cyangwa metastatike, ariko bigomba gutangwa hakurya y'inzitizi y'amaraso n'ubwonko, idashobora kwambuka byoroshye.
Mugusoza, paclitaxel apis ifite akamaro gakomeye mubice byinshi bya kanseri.Mu kubangamira igabana ry'uturemangingo twibibyimba, birabuza cyane gukura no gukwirakwiza ingirabuzimafatizo za kanseri, bitanga ibyiringiro n'amahirwe yo kuvura abarwayi.Ariko,paclitaxelkwivuza kandi bifitanye isano n'ingaruka zimwe na zimwe, bityo gahunda yo kuvura igomba kugenwa hakurikijwe imiterere yihariye yumurwayi ndetse n’icyifuzo cya muganga cyo kongera umusaruro no kugabanya ingaruka mbi.
Icyitonderwa: Inyungu zishobora gukoreshwa muri iyi ngingo zikomoka mubitabo byatangajwe.
Yunnan Hande Biotechnology Co., Ltd yibanze ku musaruro wa paclitaxel mu myaka 26, kandi ni uruganda rwigenga rukora imiti ikuramo imiti irwanya kanseri paclitaxel API yemejwe na Amerika FDA, Uburayi EDQM, Ositaraliya TGA, Ubushinwa CFDA , Ubuhinde, Ubuyapani n’izindi nzego zishinzwe kugenzura igihugu.Yunnan Hande paclitaxel, gutanga isoko, kugurisha uruganda rutaziguye, urakaza neza kubaza, 18187887160 (WhatsApp numero imwe)
Igihe cyo kohereza: Ukwakira-16-2023